|
1
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma
H, Yu D, Maitikabili A, Xiao H, Zhang C, et al: MicroRNA-543
suppresses colorectal cancer growth and metastasis by targeting
KRAS, MTA1 and HMGA2: Oncotarget. 7:21825–21839. 2016.
|
|
4
|
Lan YT, Yang, Chang SC, Liang WY, Li AF,
Wang HS, Jiang JK, Chen WS, Lin TC and Lin JK: Analysis of the
seventh edition of American Joint Committee on colon cancer
staging. Int J Colorectal Dis. 27:657–663. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kala R, Peek GW, Hardy TM and Tollefsbol
TO: MicroRNAs: An emerging science in cancer epigenetics. J Clin
Bioinforma. 3:62013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu X, Wu G, Wu Z, Yao X and Li G: miR-200a
suppresses the proliferation and metastasis in pancreatic ductal
adenocarcinoma through downregulation of DEK gene. Transl Oncol.
9:25–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du Y, Liu XH, Zhu HC, Wang L, Ning JZ and
Xiao CC: miR-543 Promotes proliferation and epithelial-mesenchymal
transition in prostate cancer via targeting RKIP. Cell Physiol
Biochem. 41:1135–1146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang H, Sun Z, Wang Y, Hu Z, Zhou H, Zhang
L, Hong B, Zhang S and Cao X: miR-33-5p, a novel mechano-sensitive
microRNA promotes osteoblast differentiation by targeting Hmga2.
Sci Rep. 6:231702016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rak B, Mehlich D, Garbicz F, Domosud Z,
Paskal W, Marczewska JM and Włodarski PK: Post-transcriptional
regulation of MMP16 and TIMP2 expression via miR-382, miR-410 and
miR-200b in endometrial cancer. Cancer Genomics Proteomics.
14:389–401. 2017.PubMed/NCBI
|
|
11
|
Yang N, Chen J, Zhang H, Wang X, Yao H,
Peng Y and Zhang W: LncRNA OIP5-AS1 loss-induced microRNA-410
accumulation regulates cell proliferation and apoptosis by
targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple
myeloma. Cell Death Dis. 8:e29752017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ke X, Yuan Y, Guo C, Yang Y, Pu Q, Hu X,
Tang K, Luo X, Jiang Q, Su X, et al: miR-410 induces stemness by
inhibiting Gsk3β but upregulating β-catenin in non-small cells lung
cancer. Oncotarget. 8:11356–11371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang YF, Yu Y and Song WZ: miR-410-3p
suppresses breast cancer progression by targeting Snail. Oncol Rep.
36:480–486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Fu J, Jiang M, Zhang X, Cheng L,
Xu X, Fan Z, Zhang J, Ye Q and Song H: miR-410 is overexpressed in
liver and colorectal tumors and enhances tumor cell growth by
silencing FHL1 via a direct/indirect mechanism. PLoS One.
9:e1087082014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Shi C, Zhao J and Li B: Long
noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect
of miR-410 on the down-regulation of ITPKB in human HCT-116 and
HCT-8 cells. Oncotarget. 8:92855–92863. 2017.PubMed/NCBI
|
|
16
|
Liu C, Zhang A, Cheng L and Gao Y: miR-410
regulates apoptosis by targeting Bak1 in human colorectal cancer
cells. Mol Med Rep. 14:467–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2ˆ(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
18
|
Hussain H and Chong NF: Combined overlap
extension PCR method for improved site directed mutagenesis. Biomed
Res Int. 2016:80415322016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Winawer S, Fletcher R, Rex D, Bond J, Burt
R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, et al:
Colorectal cancer screening and surveillance: Clinical guidelines
and rationale-Update based on new evidence. Gastroenterology.
124:544–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu W, Sun M, Zou GM and Chen J: MicroRNA
and cancer: Current status and prospective. Int J Cancer.
120:953–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okato A, Goto Y, Kurozumi A, Kato M,
Kojima S, Matsushita R, Yonemori M, Miyamoto K, Ichikawa T and Seki
N: Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in
prostate cancer. Int J Oncol. 49:111–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang
C, Wu S, Yu D, Huang Z, Liu F, et al: MicroRNA-33b inhibits breast
cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep.
5:99952015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wen R, Umeano AC, Essegian DJ,
Sabitaliyevich UY, Wang K and Farooqi AA: Role of microRNA-410 in
molecular oncology: A double edged sword. J Cell Biochem. Aug
7–2018.(Epub ahead of print). View Article : Google Scholar
|
|
25
|
Wu H, Li J, Guo E, Luo S and Wang G:
miR-410 acts as a tumor suppressor in estrogen receptor-positive
breast cancer cells by directly targeting ERLIN2 via the ERS
pathway. Cell Physiol Biochem. 48:461–474. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ke Z, He W, Lai Y, Guo X, Chen S, Li S,
Wang Y and Wang L: Overexpression of collagen triple helix repeat
containing 1 (CTHRC1) is associated with tumour aggressiveness and
poor prognosis in human non-small cell lung cancer. Oncotarget.
5:9410–9424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sethi JK and Vidal-Puig A: Wnt signalling
and the control of cellular metabolism. Biochem J. 427:1–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukumoto S, Hsieh CM, Maemura K, Layne MD,
Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Rubin JS, et al:
Akt participation in the Wnt signaling pathway through Dishevelled.
J Biol Chem. 276:17479–17483. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Glinka A, Wu W, Delius H, Monaghan AP,
Blumenstock C and Niehrs C: Dickkopf-1 is a member of a new family
of secreted proteins and functions in head induction. Nature.
391:357–362. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Niehrs C: Function and biological roles of
the Dickkopf family of Wnt modulators. Oncogene. 25:7469–7481.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aguilera O, Fraga MF, Ballestar E, Paz MF,
Herranz M, Espada J, García JM, Muñoz A, Esteller M and
González-Sancho JM: Epigenetic inactivation of the Wnt antagonist
DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene.
25:4116–4121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z, Sun B, Qi L, Li Y, Zhao X, Zhang D
and Zhang Y: Dickkopf-1 expression is down-regulated during the
colorectal adenoma-carcinoma sequence and correlates with reduced
microvessel density and VEGF expression. Histopathology.
67:158–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pamuk GE, Uyanik MS, Pamuk ON, Maden M and
Tapan U: Decreased dickkopf-1 levels in chronic lymphocytic
leukemia and increased osteopontin levels in non-Hodgkin's lymphoma
at initial diagnosis: Could they be playing roles in pathogenesis?
Hematology. 20:267–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cho SW, Kim YA, Sun HJ, Ahn HY, Lee EK, Yi
KH, Oh BC, Park DJ, Cho BY and Park YJ: Therapeutic potential of
Dickkopf-1 in wild-type BRAF papillary thyroid cancer via
regulation of β-catenin/E-cadherin signaling. J Clin Endocrinol
Metab. 99:E1641–E1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
